Product Information

TERIFLUNOMIDE 7 MG TABLET is a generic product labeled by Zydus Pharmaceuticals (USA) Inc., priced at $0.3176 per EA under NDC 70710111403. Its NADAC has been published 131 times since May 22, 2024.

FDA first approved this application on Nov 30, 2018. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

TERIFLUNOMIDE 7 MG TABLET

Teriflunomide
$0.3176per EA

Strength

7 mg/1

NDC

70710111403

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Effective Date

11/18/2026

Active Ingredients

TERIFLUNOMIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA209668

FDA Approved

11/30/2018

TE Code

AB

On Market Since

2/14/2023

Pharmacological Classes

Dihydroorotate Dehydrogenase Inhibitors
Pyrimidine Synthesis Inhibitor

Price Statistics

The NADAC for TERIFLUNOMIDE 7 MG TABLET has been published 131 times since May 22, 2024, and over the history we have for it it has declined 47.5%. The table below summarizes its recorded NADAC range and movement.

Current price$0.3176 per EA
All-time high$0.6572 (Mar 11, 2026)
All-time low$0.2917 (Aug 19, 2026)
52-week high$0.6572
52-week low$0.2917
Median price$0.5419
Average price$0.4982
Largest weekly change-28.7% (May 20, 2026)
Weeks tracked131
Tracking sinceMay 22, 2024

Price History

1W

+4.3%

1M

+8.8%

3M

+8.9%

6M

-2.6%

1Y

-46.5%

3Y

N/A

5Y

N/A

All

-47.5%

Generic Alternatives

The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of TERIFLUNOMIDE 7 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for TERIFLUNOMIDE 7 MG TABLET, manufactured by Zydus Pharmaceuticals (USA) Inc., is $0.3176 per EA (NDC 70710111403), effective Nov 18, 2026.

How has the price of TERIFLUNOMIDE 7 MG TABLET changed over time?

Over the history we have for it, the NADAC for TERIFLUNOMIDE 7 MG TABLET has declined 47.5%. It has been tracked across 131 weekly CMS publications since May 22, 2024.

What are the highest and lowest recorded NADAC prices for TERIFLUNOMIDE 7 MG TABLET?

Since May 22, 2024, the NADAC for TERIFLUNOMIDE 7 MG TABLET has ranged from a low of $0.2917 (Aug 19, 2026) to a high of $0.6572 (Mar 11, 2026), with a median of $0.5419 per EA.

Are there cheaper alternatives to TERIFLUNOMIDE 7 MG TABLET?

5 manufacturers publish a NADAC-priced product with the same active ingredient and strength as TERIFLUNOMIDE 7 MG TABLET in a comparable dosage form, but none are currently priced below it.

Who manufactures TERIFLUNOMIDE 7 MG TABLET?

TERIFLUNOMIDE 7 MG TABLET (NDC 70710111403) is labeled by Zydus Pharmaceuticals (USA) Inc., and CMS classifies it as a generic product.